식품의약품안전처에서 1일 섭취허용량을 설정한 니트로사민류 불순물 목록 (9차, 기준일 2025-02-18)이 게재되었습니다.

< 변경 이력표 >
순번
|
기준일
|
변경사항
|
1차
|
2023-12-13
|
최초 게재
|
2차
|
2024-01-18
|
신규 6종 추가
|
3차
|
2024-03-20
|
신규 21종 추가, 변경 1종(N-nitroso-ambroxol)
|
4차
|
2024-06-21
|
변경 2종(N-nitroso-varenicline 등)
|
5차
|
2024-10-25
|
변경 1종(NTTP)
|
6차
|
2024-11-06
|
변경 1종(NNORT)
|
7차
|
2024-12-04
|
신규 12종 추가, 변경 3종, 명칭 변경 2종
|
8차
|
2025-01-09
|
신규 2종 추가, 변경 1종(MeNP)
|
9차
|
2025-02-18
|
신규 8종 추가, 변경 2종(N-nitroso-sertraline 등)
|
< 신규 8종 >
1. N-nitroso-2,4-thiazole amine / N-((2-isopropylthiazol-4-yl)methyl)-N-methylnitrous amide (NNTA)
- 리토나비르(Ritonavir) 관련, 검토중, 추후 확정 예정
2. N-(2-hydroxy-2-phenylethyl)-N-(4-nitrophenethyl)nitrous amide
- 미라베그론(Mirabegron) 관련, 400 ng/일
3. N-(4-aminophenethyl)-N-(2-hydroxy-2-phenylethyl)nitrous amide
- 미라베그론(Mirabegron) 관련, 400 ng/일
4. 3-(dimethylamino)propyl 2-[benzyl(nitroso)amino]benzoate (3DPN)
- 벤지다민(Benzydamine) 관련, 400 ng/일
5. N-nitroso-buspirone Impurity 1 / 2-(4-nitrosopiperazine-1-yl)-pyrimidine
- 부스피론(Buspirone) 관련, 400 ng/일
6. N-nitroso-silodosin
- 실로도신(Silodosin) 관련, 1,500 ng/일
7. N-nitroso-desmethyl-edoxaban
- 에독사반(Edoxaban) 관련, 100 ng/일
8. N-nitroso-epinephrine
- 에피네프린(Epinephrine) 관련, 100 ng/일
< 변경 2종 >
1. N-nitroso-N-methylaniline (NMPA)
- (기존) 검토중, 추후 확정 예정 → (변경) 100 ng/일
2. N-nitroso-sertraline
- 설트랄린(Sertraline) 관련, (기존) 검토중, 추후 확정 예정 → (변경) 100 ng/일
식약처 설정 니트로사민류 불순물 1일 섭취허용량
|
||||||
|
|
|
|
|
기준일 : 2025.2.18.
|
|
연번
|
불순물 명칭
|
발생 성분
|
CPCA분류
|
섭취허용량
(ng/일) |
비고
|
공개일자
|
1
|
N-nitrosodi-methylamine, NDMA
|
-
|
-
|
96
|
-
|
2018-08-06
|
2
|
N-nitrosodi-ethylamine, NDEA
|
-
|
-
|
26.5
|
-
|
2018-11-20
|
3
|
N-nitroso-di-n-butylamine, NDBA
|
-
|
-
|
26.5
|
SAR/read-across,
참조물질 NDEA |
2021-11-09
|
4
|
N-nitrosodipropylamine, NDPA
|
-
|
-
|
26.5
|
SAR/read-across,
참조물질 NDEA |
2021-11-18
|
5
|
N-nitrosomorpholine, NMOR
|
-
|
-
|
127
|
-
|
2022-02-17
|
6
|
N-nitroso-piperidine, NPIP
|
-
|
-
|
1,300
|
-
|
2023-12-13
|
7
|
N-nitroso-pyrrolidine, NPYR
|
-
|
-
|
1,700
|
-
|
2023-12-13
|
8
|
N-nitroso-diisopropylamine (NDIPA)
|
-
|
5
|
1,500
|
-
|
2024-12-04
|
9
|
N-nitroso-ethylisopropylamine (NEIPA)
|
-
|
3
|
400
|
-
|
2024-12-04
|
10
|
N-nitroso-N-methyl-4-aminobutyric acid (NMBA)
|
-
|
4
|
1,500
|
-
|
2024-12-04
|
11
|
1-methyl-4-nitrosopiperazine (MeNP)
|
-
|
3
|
400
|
-
|
2025-01-09
|
12
|
N-nitroso-N-methylaniline (NMPA)
|
-
|
2
|
100
|
-
|
2025-02-18
|
13
|
2-nitroso-octahydrocyclopenta(c)pyrrole
|
글리클라지드(Gliclazide)
|
-
|
1,700
|
SAR/read-across, 참조물질 NPYR3)
|
2023-12-13
|
14
|
N-nitroso-nebivolol, NNEB
|
네비보롤(Nebivolol)
|
4
|
1,500
|
-
|
2023-12-13
|
15
|
N-nitroso-nortriptyline (NNORT)
|
노르트립틸린(Nortriptyline)
아미트립틸린(Amitriptyline) |
1
|
26.5
|
-
|
2024-11-06
|
16
|
N-nitroso-desmethyl-nintedanib
|
닌테다닙(Nintedanib)
|
3
|
400
|
-
|
2024-03-20
|
17
|
N-nitroso-dabigatran etexilate
|
다비가트란(Dabigatran)
|
-
|
1,500
|
AMES 음성
|
2024-06-21
|
18
|
N-nitroso-desloratadine
|
데스로라타딘(Desloratadine)
|
3
|
400
|
-
|
2023-12-13
|
19
|
N-nitroso-N-desmethyl-desvenlafaxine
|
데스벤라팍신(Desvenlafaxine)
|
1
|
26.5
|
-
|
2023-12-13
|
20
|
N-nitroso-N-desmethyl-dextromethorphan
|
덱스트로메토르판(Dextromethorphan)
|
4
|
1,500
|
-
|
2024-12-04
|
21
|
N-nitroso-dorzolamide
|
도르졸라미드(Dorzolamide)
|
2
|
100
|
-
|
2023-12-13
|
22
|
N-nitroso-nordoxepin
|
독세핀(Doxepin)
|
1
|
26.5
|
-
|
2023-12-13
|
23
|
N-desmethyl-N-nitroso-doxycycline
|
독시사이클린(Doxycycline)
|
3
|
400
|
-
|
2023-12-13
|
24
|
N-nitroso-N-methyl-2-[1-phenyl-1-(2-pyridinyl)methoxy]ethanamine
|
독실아민(Doxylamine)
|
1
|
26.5
|
-
|
2023-12-13
|
25
|
N-nitroso-duloxetine
|
둘록세틴(Duloxetine)
|
-
|
100
|
SAR/read-across, 참조물질 NNK1)
|
2023-12-13
|
26
|
N-nitroso-N-desmethyl-diphenhydramine
|
디멘히드리네이트(Dimenhydrinate)
디펜히드라민(Diphenhydramine) |
1
|
26.5
|
|
2025-01-09
|
27
|
N-nitroso-diclofenac
|
디클로페낙(Diclofenac)
|
5
|
1,500
|
-
|
2023-12-13
|
28
|
N-nitroso-ranolazine impurity 1
|
라놀라진(Ranolazine)
|
3
|
400
|
-
|
2024-03-20
|
29
|
N-nitroso-ramipril
|
라미프릴(Ramipril)
|
5
|
1,500
|
-
|
2023-12-13
|
30
|
N-nitroso-labetalol
|
라베타롤(Labetalol)
|
4
|
1,500
|
-
|
2023-12-13
|
31
|
N-nitroso-rasagiline
|
라사길린(Rasagiline)
|
2
|
100
|
-
|
2023-12-13
|
32
|
N-nitroso-levofloxacin
|
레보플록사신(Levofloxacin)
|
4
|
1,500
|
-
|
2023-12-13
|
33
|
N-nitroso-2,6-pipecoloxilidide
|
로피바카인(Ropivacaine)
|
4
|
1,500
|
-
|
2023-12-13
|
34
|
N-nitroso-folinic acid: N-[4-[[(2-amino-5-formyl-3,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl)methyl]nitrosoamino]benzoyl]-L-glutamic acid
|
류코보린(Leucovorin)
|
4
|
1,500
|
-
|
2023-12-13
|
35
|
N-nitroso-desethyllidocaine
|
리도카인(Lidocaine)
|
2
|
100
|
-
|
2024-03-20
|
36
|
N-Nitroso-rivaroxaban amide /
(S)-5-chloro-N-(2-hydroxy-3-(nitroso (4-(3-oxomorpholino)phenyl)amino) propyl)thiophene-2-carboxamide |
리바록사반(Rivaroxaban)
|
4
|
1,500
|
-
|
2024-03-20
|
37
|
N-Nitroso-rivaroxaban open-ring acid /
(S)-2-(2-((4-(5-((5-chlorothiophene-2-carboxa(nitrosmido)methyl)-2-oxooxazolidin-3-yl)phenyl)o)amino)ethoxy) acetic acid |
리바록사반(Rivaroxaban)
|
4
|
1,500
|
-
|
2024-03-20
|
38
|
Rivaroxaban Nitroso Impurity 1 /
N-(2-hydroxyethyl)-N-phenyl-nitrous amide |
리바록사반(Rivaroxaban)
|
4
|
1,500
|
-
|
2024-12-04
|
39
|
Rivaroxaban Nitroso Impurity 2 /
N-(3-(1,3-dioxoisoindolin-2-yl)-2-hydroxypropyl)-N-(4-(3-oxomorpholino) phenyl)nitrous amide |
리바록사반(Rivaroxaban)
|
4
|
1,500
|
-
|
2024-12-04
|
40
|
Rivaroxaban Nitroso Impurity 5 /
N-(3-Chloro-2-hydroxypropyl)-N-(4-(3-oxomorpholino)phenyl)nitrous amide |
리바록사반(Rivaroxaban)
|
4
|
1,500
|
-
|
2024-12-04
|
41
|
N-nitroso-N-desmethyl rivastigmine
|
리바스티그민(Rivastigmine)
|
2
|
100
|
-
|
2023-12-13
|
42
|
N-nitroso-ribociclib impurity 1
|
리보시클립(Ribociclib)
|
3
|
400
|
-
|
2024-03-20
|
43
|
N-nitroso-lisinopril
|
리시노프릴(Linsinopril)
|
5
|
1,500
|
-
|
2023-12-13
|
44
|
N-nitroso-2,4-thiazole amine /
N-((2-isopropylthiazol-4-yl)methyl)-N-methylnitrous amide (NNTA) |
리토나비르(Ritonavir)
|
-
|
검토중,
추후 확정 예정 |
-
|
-
|
45
|
N-nitroso-meropenem
|
메로페넴(Meropenem)
|
4
|
1,500
|
-
|
2023-12-13
|
46
|
N-nitroso-metoprolol
|
메토프롤롤(Metoprolol)
|
4
|
1,500
|
-
|
2023-12-13
|
47
|
N-nitroso-methylphenidate, NMPH
|
메틸페니데이트(Methylphenidate)
|
-
|
1,300
|
SAR/read-across, 참조물질 NPIP2)
|
2023-12-13
|
48
|
N-nitroso-moxifloxacin
|
목시플록사신(Moxifloxacin)
|
4
|
1,500
|
-
|
2023-12-13
|
49
|
N-(2-hydroxy-2-phenylethyl)-N-(4-nitrophenethyl)nitrous amide
|
미라베그론(Mirabegron)
|
3
|
400
|
-
|
2025-02-18
|
50
|
N-(4-aminophenethyl)-N-(2-hydroxy-2-phenylethyl)nitrous amide
|
미라베그론(Mirabegron)
|
3
|
400
|
-
|
2025-02-18
|
51
|
N-nitroso-mirabegron
|
미라베그론(Mirabegron)
|
3
|
400
|
-
|
2023-12-13
|
52
|
N-nitroso-mirtazapine
|
미르타자핀(Mirtazapine)
|
3
|
400
|
-
|
2024-03-20
|
53
|
N-nitroso-varenicline, NNV
|
바레니클린(Varenicline)
|
3
|
400
|
-
|
2024-06-21
|
54
|
N-nitroso-N-ethyl-valacyclovir
|
발라시클로비르(Valacyclovir)
|
3
|
400
|
-
|
2023-12-13
|
55
|
N-nitroso-N-methyl-valacyclovir
|
발라시클로비르(Valacyclovir)
|
3
|
400
|
-
|
2023-12-13
|
56
|
N-nitroso-valsartan cyano-desvalerylmethylester
|
발사르탄(Valsartan)
|
2
|
100
|
-
|
2024-12-04
|
57
|
N-nitroso-betahistine
|
베타히스틴(Betahisitne)
|
1
|
26.5
|
-
|
2023-12-13
|
58
|
N-nitroso-betaxolol
|
베탁솔롤(Betaxolol)
|
4
|
1,500
|
-
|
2024-03-20
|
59
|
3-(dimethylamino)propyl 2-[benzyl(nitroso)amino]benzoate (3DPN)
|
벤지다민(Benzydamine)
|
3
|
400
|
-
|
2025-02-18
|
60
|
N-nitroso-vortioxetine
|
보티옥세틴(Vortioxetine)
|
3
|
400
|
-
|
2023-12-13
|
61
|
N-nitroso-buspirone Impurity 1 /
2-(4-nitrosopiperazine-1-yl)-pyrimidine |
부스피론(Buspirone)
|
3
|
400
|
-
|
2025-02-18
|
62
|
N-nitroso-bupropion
|
부프로피온(Bupropion)
|
5
|
1,500
|
-
|
2023-12-13
|
63
|
N-nitroso-bisoprolol, NBP
|
비소프롤롤(Bisoprolol)
|
4
|
1,500
|
-
|
2023-12-13
|
64
|
N-nitroso vildagliptin amide impurity
|
빌다글립틴(Vildagliptin)
|
5
|
1,500
|
-
|
2024-12-04
|
65
|
N-nitroso-vildagliptin
|
빌다글립틴(Vildagliptin)
|
5
|
1,500
|
-
|
2023-12-13
|
66
|
N-nitroso-salbutamol
|
살부타몰(Salbutamol)
|
5
|
1,500
|
-
|
2023-12-13
|
67
|
N-nitroso-sertraline
|
설트랄린(Sertraline)
|
2
|
100
|
-
|
2025-02-18
|
68
|
N-nitroso-celiprolol
|
셀리프롤롤(Celiprolol)
|
5
|
1,500
|
-
|
2024-03-20
|
69
|
N-nitroso-sotalol
|
소타롤(Sotalol)
|
4
|
1,500
|
-
|
2023-12-13
|
70
|
3-[2-(N-nitroso-N-methyl)amino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide
|
수마프립탄(Sumatriptan)
|
1
|
26.5
|
-
|
2023-12-13
|
71
|
N-nitroso-pseudoephedrine
|
슈도에페드린(Pseudoephedrine)
|
4
|
1,500
|
-
|
2023-12-13
|
72
|
N-nitroso-cinacalcet
|
시나칼세트(Cinacalcet)
|
3
|
400
|
-
|
2024-01-18
|
73
|
2,2,5-trimethyl-3-nitroso-1,3-oxazolidine
|
시아노코발라민(Cyanocobalamine)
|
4
|
1,500
|
-
|
2024-12-04
|
74
|
7-nitroso-3-(trifluoromethyl)-5,6,7,8-tetrahydro[1,2,4]triazolo-[4,3- a]pyrazine, NTTP
|
시타글립틴(Sitagliptin)
|
2
|
100
|
-
|
2024-10-25
|
75
|
N-nitroso-desmethyl citalopram
|
시탈로프람(Citalopram)
|
1
|
26.5
|
-
|
2023-12-13
|
76
|
N-nitroso-ciprofloxacin
|
시프로플록사신(Ciprofloxacin)
|
4
|
1,500
|
-
|
2024-01-18
|
77
|
1-diphenylmethyl-4-nitrosopiperazine
|
신나리진(cinnarizine)
|
3
|
400
|
|
2025-01-09
|
78
|
N-nitroso-desmethyl-sildenafil
|
실데나필(Sildenafil)
|
3
|
400
|
-
|
2024-03-20
|
79
|
N-nitroso-cilazapril
|
실라자프릴(Cilazapril)
|
5
|
1,500
|
-
|
2023-12-13
|
80
|
N-nitroso-silodosin
|
실로도신(Silodosin)
|
4
|
1,500
|
-
|
2025-02-18
|
81
|
1-(2,3-dichlorophenyl)-4-nitrosopiperazine
|
아리피프라졸(Aripiprazole)
|
3
|
400
|
-
|
2024-03-20
|
82
|
N-nitroso-desmethyl-azelastine
|
아젤라스틴(Azelastine)
|
2
|
100
|
-
|
2024-03-20
|
83
|
N-nitroso-azaerythromycin
|
아지스로마이신(Azithromycin)
|
-
|
ICH Q3A/Q3B에 따라 관리
|
비변이원성 불순물
|
2023-12-13
|
84
|
N-nitroso-desmethylazithromycin
|
아지스로마이신(Azithromycin)
|
-
|
ICH Q3A/Q3B에 따라 관리
|
비변이원성 불순물
|
2023-12-13
|
85
|
N-nitroso-atenolol
|
아테놀롤(Atenolol)
|
4
|
1,500
|
-
|
2023-12-13
|
86
|
N-nitroso-Atomoxetine
|
아토목세틴(Atomoxetine)
|
-
|
100
|
SAR/read-across, 참조물질 NNK1)
|
2024-03-20
|
87
|
N-nitroso-apixaban impurity B
|
아픽사반(Apixaban)
|
4
|
1,500
|
-
|
2024-12-04
|
88
|
3-amino-N-nitrosopiperidine
|
알로글립틴(Alogliptin)
|
3
|
400
|
-
|
2024-01-18
|
89
|
N-nitroso-ambroxol
|
암브록솔(Ambroxol)
|
-
|
1,500
|
AMES 음성
|
2024-03-20
|
90
|
N-nitroso-enalapril
|
에날라프릴(Enalapril)
|
5
|
1,500
|
-
|
2023-12-13
|
91
|
N-nitroso-desmethyl-edoxaban
|
에독사반(Edoxaban)
|
2
|
100
|
-
|
2025-02-18
|
92
|
N-nitroso-esmolol
|
에스몰롤(Esmolol)
|
4
|
1,500
|
-
|
2024-01-18
|
93
|
N-nitroso-epinephrine
|
에피네프린(Epinephrine)
|
2
|
100
|
-
|
2025-02-18
|
94
|
N-nitroso-folic acid, NFA
|
엽산/폴산(Folic acid)
|
4
|
1,500
|
-
|
2023-12-13
|
95
|
N-nitroso-N-desmethylorphenadrine, NMOA
|
오르페나드린(Orphenadrine)
|
1
|
26.5
|
-
|
2023-12-13
|
96
|
N-nitroso-imatinib
|
이매티닙(Imatinib)
|
5
|
1,500
|
-
|
2024-03-20
|
97
|
N-nitroso-ethylenediamine-triacetic acid
|
이소소르비드 모노니트레이트
(Isosorbide mononitrate) |
4
|
1,500
|
-
|
2024-03-20
|
98
|
N-nitroso-iminodiacetic acid
|
이소소르비드 모노니트레이트
(Isosorbide mononitrate) |
4
|
1,500
|
-
|
2024-03-20
|
99
|
Indapamide Impurity A
|
인다파미드(Indapamide)
|
5
|
1,500
|
-
|
2024-03-20
|
100
|
N-nitroso-ketamine
|
케타민(Ketamine)
|
5
|
1,500
|
-
|
2023-12-13
|
101
|
N-nitroso Quetiapine HEEP Impurity
|
쿠에티아핀(Quetiapine)
|
-
|
1,500
|
AMES 음성
|
2024-03-20
|
102
|
N-nitroso-aryl piperazine / N-nitroso-desalkylquetiapine, NDAQ
|
쿠에티아핀(Quetiapine)
|
3
|
400
|
-
|
2023-12-13
|
103
|
N-nitroso-N-desmethyl clarithromycin
|
클래리트로마이신(Clarithromycin)
|
4
|
1,500
|
-
|
2023-12-13
|
104
|
N-nitroso-cloazpine
|
클로자핀(Cloazpine)
|
5
|
1,500
|
-
|
2023-12-13
|
105
|
N-nitroso-tigecycline
|
타이가사이클린(Tigecycline)
|
5
|
1,500
|
-
|
2023-12-13
|
106
|
N-nitroso-tamsulosin
|
탐스로신(Tamsulosin)
|
4
|
1,500
|
-
|
2023-12-13
|
107
|
N-nitroso terazosin impurity C /
6, 7-Dimethoxy-2-(1-piperazinyl)-4-quinazolinamine; 2-(1-Piperazinyl)-4-amino-6, 7-dimethoxyquinazoline |
테라조신(Terazosin)
|
3
|
400
|
-
|
2024-12-04
|
108
|
N-nitroso terazosin impurity N /
(4-Nitrosopiperazin-1-yl) (tetrahydrofuran-2-yl)methanone |
테라조신(Terazosin)
|
3
|
400
|
-
|
2024-12-04
|
109
|
N-nitroso-desmethyl terbinafine
|
테르비나핀(Terbinafine)
|
1
|
26.5
|
-
|
2024-03-20
|
110
|
N-nitroso-terbinafine impurity A
|
테르비나핀(Terbinafine)
|
1
|
26.5
|
-
|
2024-03-20
|
111
|
N-nitroso-tetracaine
|
테트라카인(Tetracaine)
|
3
|
400
|
-
|
2024-01-18
|
112
|
N-nitroso-desmethyl-tramadol
|
트라마돌(Tramadol)
|
1
|
26.5
|
-
|
2024-12-04
|
113
|
N-nitroso-desmethyl trimebutine
|
트리메부틴(Trimebutine)
|
5
|
1,500
|
-
|
2023-12-13
|
114
|
N-nitroso-trimetazidine, NTMZ
|
트리메타지딘(Trimetazidine)
|
3
|
400
|
-
|
2023-12-13
|
115
|
N-nitroso-ticagrelor
|
티카그렐러(Ticagrelor)
|
5
|
1,500
|
-
|
2024-01-18
|
116
|
N-nitroso-paroxetine
|
파록세틴(Paroxetine)
|
-
|
1,300
|
SAR/read-across, 참조물질 NPIP2)
|
2023-12-13
|
117
|
N-nitroso-phenylephrine
|
페닐레프린(Phenylephrine)
|
2
|
100
|
-
|
2023-12-13
|
118
|
N-nitroso-perindopril
|
페린도프릴(Perindopril)
|
5
|
1,500
|
-
|
2023-12-13
|
119
|
N-nitroso-felodipine
|
펠로디핀(Felodipine)
|
5
|
1,500
|
-
|
2023-12-13
|
120
|
N-nitroso-calcium folinate
|
폴리네이트칼슘
(Calcium folinate/ Calcium levofolinate) |
-
|
ICH Q3A/Q3B에 따라 관리
|
비변이원성 불순물
|
2024-03-20
|
121
|
N-nitroso-furosemide
|
푸로세미드(Furosemide)
|
4
|
1,500
|
-
|
2023-12-13
|
122
|
N-nitroso-pramipexole
|
프라미펙솔(Pramipexole)
|
3
|
400
|
-
|
2023-12-13
|
123
|
N-nitroso-frovatriptan/(3R)-2,3,4,9-tetrahydro-3-(N-methyl(nitroso)amino)-1H-carbazole-6-carboxamide
|
프로바트립탄(Frovatriptan)
|
3
|
400
|
-
|
2023-12-13
|
124
|
N-nitroso-propanolol
|
프로프라놀롤(Propanolol)
|
4
|
1,500
|
-
|
2023-12-13
|
125
|
N-nitroso-flecainide
|
플레카이니드(Flecainide)
|
4
|
1,500
|
-
|
2023-12-13
|
126
|
N-nitroso-fluoxetine
|
플루옥세틴(Fluoxetine)
|
-
|
100
|
SAR/read-across, 참조물질 NNK1)
|
2023-12-13
|
127
|
N-nitroso-hydrochlorothiazide
|
히드로클로로티아지드(Hydrochlorothiazide)
|
-
|
ICH Q3A/Q3B에 따라 관리
|
비변이원성 불순물
|
2023-12-13
|
|
|
|
|
|
|
|
1) NNK : 4-(methylnitrosoamino)-1-(3-pyridinyl)-1-butanone
2) NPIP : N-nitroso-piperidine 3) NPYR : N-nitroso-pyrrolidine |
(2025-02-18) 식약처 설정 니트로사민류 불순물 1일 섭취허용량 목록 갱신 (9차)
식품의약품안전처에서 1일 섭취허용량을 설정한 니트로사민류 불순물 목록 (9차, 기준일 2025-02-18)이 게...
blog.naver.com
'식약처 규정 지침 > 제개정고시등' 카테고리의 다른 글
(2024-12-30) 「의약품 등의 안전에 관한 규칙」 일부개정령(총리령 제2003호) 공포 알림 (0) | 2025.02.25 |
---|---|
(2025-01-16) 「의약품 표준제조기준」 일부개정 고시 알림 (0) | 2025.02.25 |
(2025-01-31) 2024년 신약 지정 목록 공고 (2024년 신약 목록 변경 내역) (0) | 2025.02.07 |
(2024-12-30) 「의약품 제조 및 품질관리에 관한 규정」 일부개정고시 (0) | 2025.02.07 |
[과거 자료] 갱신된 정보 확인 필수! - (2025-01-09) 식약처 설정 니트로사민류 불순물 1일 섭취허용량 목록 갱신 (1) | 2025.02.07 |